Literature DB >> 18174550

Intrafamilial phenotypic variability in tuberous sclerosis complex.

David A Lyczkowski1, Kerry D Conant, Margaret B Pulsifer, Delma Y Jarrett, P Ellen Grant, David J Kwiatkowski, Elizabeth A Thiele.   

Abstract

Clinical manifestations were retrospectively assessed in 5 families with tuberous sclerosis complex, including 1 pair of monozygotic twins. Interfamilial variation in tuber count was significantly larger than intrafamilial variation. Severity of epilepsy and cognitive profiles varied both between and within families, particularly between the monozygotic twins, and IQ was inversely related to tuber count. Cutaneous, renal, and cardiac findings did not appear to cluster within families. Although the monozygotic twins displayed similar physical manifestations of tuberous sclerosis complex (renal and cardiac hamartomas), they differed markedly in neurocognitive profiles. Phenotypic variation within these families may be explained largely as a function of the randomness of second-hit events that cause hamartomas in tuberous sclerosis complex or by as-yet-unidentified genetic modifiers. Familial variation in tuberous sclerosis complex phenotype has important implications for genetic counseling.

Entities:  

Mesh:

Year:  2007        PMID: 18174550     DOI: 10.1177/0883073807307093

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

1.  Clinical utility gene card for: tuberous sclerosis complex (TSC1, TSC2).

Authors:  Karin Mayer; Christa Fonatsch; Katharina Wimmer; Ans M W van den Ouweland; Anneke J A Maat-Kievit
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

2.  Genotype and brain pathology phenotype in children with tuberous sclerosis complex.

Authors:  Iris E Overwater; Rob Swenker; Emma L van der Ende; Kimberley Bm Hanemaayer; Marianne Hoogeveen-Westerveld; Agnies M van Eeghen; Maarten H Lequin; Ans Mw van den Ouweland; Henriëtte A Moll; Mark Nellist; Marie-Claire Y de Wit
Journal:  Eur J Hum Genet       Date:  2016-07-13       Impact factor: 4.246

3.  Evidence for population variation in TSC1 and TSC2 gene expression.

Authors:  Garilyn M Jentarra; Stephen G Rice; Shannon Olfers; David Saffen; Vinodh Narayanan
Journal:  BMC Med Genet       Date:  2011-02-23       Impact factor: 2.103

4.  Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings.

Authors:  R C Caylor; L Grote; I Thiffault; E G Farrow; L Willig; S Soden; S M Amudhavalli; A J Nopper; K A Horii; E Fleming; J Jenkins; H Welsh; M Ilyas; K Engleman; A Abdelmoity; C J Saunders
Journal:  Neurogenetics       Date:  2018-06-20       Impact factor: 2.660

5.  Semi-automatic volumetry of cortical tubers in tuberous sclerosis complex.

Authors:  Yasuhiro Nakata; Noriko Sato; Ayako Hattori; Kimiteru Ito; Yukio Kimura; Kouhei Kamiya; Yoko Shigemoto; Eiji Nakagawa; Masayuki Sasaki; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2013-02-02       Impact factor: 2.374

6.  Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex.

Authors:  Philippe Major
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

7.  Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.

Authors:  Won Seop Kim
Journal:  Korean J Pediatr       Date:  2011-06-30

8.  A novel TSC2 missense variant associated with a variable phenotype of tuberous sclerosis complex: case report of a Chinese family.

Authors:  Feng Wang; Shiyi Xiong; Lin Wu; Maya Chopra; Xihong Hu; Bingbing Wu
Journal:  BMC Med Genet       Date:  2018-05-30       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.